Reason: Failed Dissolution Specifications: Three lots of product being recalled having failed stability dissolution testing.
Distributed: Nationwide and Puerto Rico.Reason: CGMP Deviation: Discoloration; Product fails specification for appearance/color. A complaint was received regarding an abnormal appearance of children's ibuprofen suspension.
Distributed: GA, KY, TNReason: Presence of Foreign Tablets/Capsules: Potential of Pravastatin tablet fragments in bottles of Valacyclovir 1 gm Tablets.
Distributed: NationwideReason: Failed Tablet/Capsule Specifications: Broken tablets
Distributed: NationwideReason: Failed Dissolution Specification; the bulk lot yielded an out of specification result at the 8 hr timepoint, 18 month interval
Distributed: US Nationwide (including PR)Reason: Failed Dissolution Specification; 8 hr stability timepoint
Distributed: US nationwide (including PR)Reason: Presence of Particulate Matter; particulate matter in one vial identified as silicone rubber and EPDM rubber from the vial stopper.
Distributed: Nationwide, Saudi Arabia and ColombiaReason: Marketed without an Approved NDA/ANDA.
Distributed: Nationwide and Puerto RicoReason: Microbial Contamination of Non-Sterile Products: Fusion Pharmaceuticals is recalling the Dicopanol FusePaq Kit due to Total Yeasts and Molds Count above USP limits.
Distributed: CAReason: Presence of Particulate Matter: The 1g Cefepime for Injection USP and Dextrose Injection USP lot has been found to contain visible organic particulate matter in a reserve sample unit.
Distributed: Nationwide